Abcellera Biologics Inc.
ABCL
Revenue
44.85M
▲35.90M▲400.88%
3 Months ChangeAssets
1.36B
▲958.00k▲0.07065%
3 Months ChangeLiabilities
390.05M
▼-1.91M▼-0.4868%
3 Months ChangeFree Cash Flow
-22.19M
▲43.66M▲66.30%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-24
Form 8-K
ID: 0001703057-26-000010
2026-01-14
Form 8-K
ID: 0001703057-26-000003
2025-12-18
Form 8-K
ID: 0001703057-25-000034
2025-11-28
Form 8-K
ID: 0001703057-25-000032
2025-11-12
Form 8-K
ID: 0001703057-25-000029
2025-11-06
Form 10-Q
ID: 0001703057-25-000025
2025-11-06
Form 8-K
ID: 0001703057-25-000024
2025-09-10
Form 8-K
ID: 0001703057-25-000018
2025-08-07
Form 10-Q
ID: 0001703057-25-000011
2025-08-07
Form 8-K
ID: 0001628280-25-038927